• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

《加拿大血液服务中心脐血库分发用于移植的脐血单位情况描述:首次分析》。

A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services' Cord Blood Bank: First Analysis.

机构信息

Stem Cells, Canadian Blood Services, Ottawa, ON K2E 8A6, Canada.

Faculty of Medicine, University of Toronto, Toronto, ON M5S 1A8, Canada.

出版信息

Curr Oncol. 2022 Dec 6;29(12):9572-9581. doi: 10.3390/curroncol29120752.

DOI:10.3390/curroncol29120752
PMID:36547166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9777040/
Abstract

BACKGROUND

The Canadian Blood Services Cord Blood Bank (CBS CBB) was created to improve access to stem cell products for transplantation for patients across ethnic groups. An analysis of distributed units is needed to assess the effectiveness of the bank to meet the needs of patients from different ethnic groups.

METHODS

A descriptive analysis was performed on all cord blood units distributed from the CBS' CBB as of 30 June 2022.

RESULTS

Distribution of the first 60 units based on CBS' CBB inventory has been linear over time. A similar proportion of cord blood unit (CBU) recipients were pediatric or adult. More than half of the cord blood units (56.7%) were distributed to recipients outside of Canada, and CBUs were used to treat a broad range of hematologic and immune disorders. 43.3% of distributed CBUs were of non-Caucasian ethnicity and 18% were from donors self-reporting as multi-ethnic. The mean total nucleated cell counts and total CD34 cell counts were 1.9 ± 0.1 × 10 cells and 5.3 ± 0.5 × 10 CD34 cells, respectively. CD34 cells per kg (recipient weight) varied significantly between pediatric (age 0-4), adolescent (age 5-17) and adult recipients (age 18 and older) (3.1 ± 0.5, 1.4 ± 0.5 and 0.9 ± 0.07 × 10 CD34 cells/kg, respectively). HLA matching was 6/6 (15%), 5/6 (47%) or 4/6 (38%).

CONCLUSIONS

The CBS' CBB has facilitated the utilization of banked units for patients across a broad range of ages, geographic distribution, ethnicity, and diseases. Distributed units were well matched for HLA alleles and contained robust cell counts, reflecting a high-quality inventory with significant utility.

摘要

背景

加拿大血液服务脐带血库(CBS CBB)的创建是为了改善不同种族群体患者的干细胞产品移植获取。需要对分发的单位进行分析,以评估该血库满足不同种族患者需求的效果。

方法

对截至 2022 年 6 月 30 日,CBS CBB 分发的所有脐带血单位进行描述性分析。

结果

根据 CBS CBB 库存,首批 60 个脐带血单位的分发呈线性增长。儿科或成年患者接受脐带血单位(CBU)的比例相似。超过一半的脐带血单位(56.7%)分发给加拿大境外的患者,CBU 用于治疗广泛的血液系统和免疫系统疾病。43.3%的分发 CBU 是非白种人,18%的 CBU 来自自我报告为多种族的供者。总核细胞计数和总 CD34 细胞计数的平均值分别为 1.9±0.1×10 个细胞和 5.3±0.5×10 CD34 细胞。儿童(0-4 岁)、青少年(5-17 岁)和成年(18 岁及以上)患者的 CD34 细胞/kg(受者体重)差异显著(分别为 3.1±0.5、1.4±0.5 和 0.9±0.07×10 CD34 细胞/kg)。HLA 配型为 6/6(15%)、5/6(47%)或 4/6(38%)。

结论

CBS CBB 促进了对广泛年龄、地理分布、种族和疾病的患者使用库存单位。分发的单位在 HLA 等位基因上具有良好的匹配性,并且细胞计数丰富,反映了具有显著实用性的高质量库存。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/ce04ef7dd59a/curroncol-29-00752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/217b891940d4/curroncol-29-00752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/e9f11dacd923/curroncol-29-00752-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/ce04ef7dd59a/curroncol-29-00752-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/217b891940d4/curroncol-29-00752-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/e9f11dacd923/curroncol-29-00752-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3993/9777040/ce04ef7dd59a/curroncol-29-00752-g003.jpg

相似文献

1
A Portrait of Cord Blood Units Distributed for Transplantation from Canadian Blood Services' Cord Blood Bank: First Analysis.《加拿大血液服务中心脐血库分发用于移植的脐血单位情况描述:首次分析》。
Curr Oncol. 2022 Dec 6;29(12):9572-9581. doi: 10.3390/curroncol29120752.
2
Reducing ethnic disparity in access to high-quality HLA-matched cord blood units for transplantation: analysis of the Canadian Blood Services' Cord Blood Bank inventory.降低高质量 HLA 匹配的脐带血单位用于移植的种族差异:对加拿大血液服务脐带血库库存的分析。
Transfusion. 2019 Jul;59(7):2382-2388. doi: 10.1111/trf.15313. Epub 2019 Apr 19.
3
HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility.加拿大血液服务中心干细胞库和脐血库中的 HLA 单倍型冗余和稀有性:优化效用的新指标。
Transfusion. 2023 Nov;63(11):2114-2119. doi: 10.1111/trf.17553. Epub 2023 Sep 26.
4
Ethnic diversity and cord blood banking: satisfying the unmet need.种族多样性与脐血库:满足未满足的需求。
Cytotherapy. 2022 Oct;24(10):1060-1066. doi: 10.1016/j.jcyt.2022.03.012. Epub 2022 May 31.
5
Optimizing donor selection for public cord blood banking: influence of maternal, infant, and collection characteristics on cord blood unit quality.优化公共脐带血库的供者选择:产妇、婴儿和采集特征对脐带血细胞质量的影响。
Transfusion. 2014 Feb;54(2):340-52. doi: 10.1111/trf.12257. Epub 2013 May 27.
6
HLA concordance between hematopoietic stem cell transplantation patients and umbilical cord blood units: Implications for cord blood banking in admixed populations.造血干细胞移植患者与脐带血单位之间的 HLA 一致性:对混合人群脐带血库的影响。
Hum Immunol. 2019 Sep;80(9):714-722. doi: 10.1016/j.humimm.2019.05.002. Epub 2019 May 14.
7
Evaluation of the impact of banking umbilical cord blood units with high cell dose for ethnically diverse patients.评估为不同种族患者储存高细胞剂量脐带血单位的影响。
Transfusion. 2018 Feb;58(2):345-351. doi: 10.1111/trf.14410. Epub 2017 Dec 1.
8
Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood Banks.盈利还是破产:维持公共脐带血库经济未来的策略
PLoS One. 2015 Dec 1;10(12):e0143440. doi: 10.1371/journal.pone.0143440. eCollection 2015.
9
Low usage rate of banked sibling cord blood units in hematopoietic stem cell transplantation for children with hematological malignancies: implications for directed cord blood banking policies.在儿童血液系统恶性肿瘤的造血干细胞移植中,脐带血库中保存的同胞脐带血使用率低:对定向脐带血库存储政策的启示。
Blood Cells Mol Dis. 2011 Feb 15;46(2):177-81. doi: 10.1016/j.bcmd.2010.10.017. Epub 2010 Nov 20.
10
Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the EUROCORD/NETCORD Bank Germany.非亲属和亲属脐带血的造血移植潜力:德国EUROCORD/NETCORD库的头六年
Klin Padiatr. 1999 Jul-Aug;211(4):224-32. doi: 10.1055/s-2008-1043793.

引用本文的文献

1
Use of non-qualifying umbilical cord blood units to support research and quality assurance by the Canadian Blood Services Cord Blood Bank.加拿大血液服务脐带血库使用不合格脐带血单位来支持研究和质量保证。
Transfusion. 2025 May;65(5):822-826. doi: 10.1111/trf.18231. Epub 2025 Mar 31.
2
Optimizing Access to Unrelated Donors in Canada: Re-Examining the Importance of Donor Factors on Outcomes Following Hematopoietic Cell Transplantation.优化加拿大非亲属供者的获取途径:重新审视供者因素对造血细胞移植后结局的重要性。
Curr Oncol. 2024 Apr 30;31(5):2542-2551. doi: 10.3390/curroncol31050190.

本文引用的文献

1
Clinical Outcomes of Umbilical Cord Blood Transplantation Using Ex Vivo Expansion: A Systematic Review and Meta-Analysis of Controlled Studies.使用体外扩增的脐带血移植的临床结局:对照研究的系统评价和荟萃分析。
Transplant Cell Ther. 2023 Feb;29(2):129.e1-129.e9. doi: 10.1016/j.jtct.2022.11.007. Epub 2022 Nov 15.
2
Ethnic diversity and cord blood banking: satisfying the unmet need.种族多样性与脐血库:满足未满足的需求。
Cytotherapy. 2022 Oct;24(10):1060-1066. doi: 10.1016/j.jcyt.2022.03.012. Epub 2022 May 31.
3
Impact of COVID-19 pandemic on global unrelated stem cell donations in 2020-Report from World Marrow Donor Association.
2020年新冠疫情对全球非血缘干细胞捐献的影响——世界骨髓捐献者协会报告
Bone Marrow Transplant. 2022 Jun;57(6):1021-1024. doi: 10.1038/s41409-022-01667-w. Epub 2022 Apr 9.
4
Impact of the SARS-CoV-2 pandemic on hematopoietic cell transplantation and cellular therapies in Europe 2020: a report from the EBMT activity survey.2020 年欧洲严重急性呼吸综合征冠状病毒 2 型大流行对造血细胞移植和细胞治疗的影响:来自 EBMT 活动调查的报告。
Bone Marrow Transplant. 2022 May;57(5):742-752. doi: 10.1038/s41409-022-01604-x. Epub 2022 Feb 22.
5
Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes.脐带血或 HLA 单倍体移植:真实世界结局与随机试验结局比较。
Transplant Cell Ther. 2022 Feb;28(2):109.e1-109.e8. doi: 10.1016/j.jtct.2021.11.002. Epub 2021 Nov 11.
6
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors.150 万例造血干细胞移植:利用非血缘关系供者使全球获得持续和差异化改善。
Haematologica. 2022 May 1;107(5):1045-1053. doi: 10.3324/haematol.2021.279189.
7
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 years.EBMT 造血细胞移植和细胞治疗调查:30 多年来活动和趋势的监测。
Bone Marrow Transplant. 2021 Jul;56(7):1651-1664. doi: 10.1038/s41409-021-01227-8. Epub 2021 Feb 23.
8
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial.双份无关脐血与 HLA 单倍体相合骨髓移植:BMT CTN 1101 试验。
Blood. 2021 Jan 21;137(3):420-428. doi: 10.1182/blood.2020007535.
9
Guidelines for Cord Blood Unit Selection.脐带血单位选择指南。
Biol Blood Marrow Transplant. 2020 Dec;26(12):2190-2196. doi: 10.1016/j.bbmt.2020.07.030. Epub 2020 Jul 28.
10
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy.造血细胞移植和免疫效应细胞治疗的适应证:美国移植和细胞治疗学会指南。
Biol Blood Marrow Transplant. 2020 Jul;26(7):1247-1256. doi: 10.1016/j.bbmt.2020.03.002. Epub 2020 Mar 9.